跳至主要内容
临床试验/NCT06879561
NCT06879561招募中不适用

Impact of Pressure Wire-guidance Versus Angiography-guidance for Infrapopliteal Artery Interventions on Post-procedural Perfusion Status and Wound Healing in Patients With Chronic Limb Threatening Ischemia (PERFECT-CLI)

Yonsei University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年10月2日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Attainment rate of postprocedural skin perfusion pressure ≥50 mmHg

研究概览

简要总结

"• A prospective, single-center randomized controlled comparison trial.

  • A total of 100 patients with symptoms of chronic limb-threatening ischemia (Rutherford category 5) undergoing endovascular treatment for anterior tibial artery or posterior tibial artery lesions will be included if they meet the inclusion criteria and do not meet any exclusion criteria.
  • Patients will be randomized in a 1:1 open-label manner either to the pressure wire-guided group or the angiography-guided group.
  • Patients will be treated with balloon angioplasty for anetrior tibial artery or posterior tibial artery lesions.
  • In the angiography-guided group, balloon angioplasty will be performed to achieve an optimal procedural result, as determined by angiography. Optimal results are defined as antegrade blood flow without residual stenosis >50% or flow-limiting dissection.
  • In the Pressure Wire-guided gorup, balloon angioplasty will be performed to obtain optimal procedural result based on both angiography and a pressure gradient over the target lesion. Optimal pressure gradient is less than 10 mmHg by measurement using a Pressure Wire.
  • The primary efficacy endpoint is defined by attaiment of skin perfusion pressure ≥50 mmHg within 1-3 days after the index procedure.
  • Patients will be followed at 1, 3, and 6 months after the procdure to assess wound healing status, and clinical events."

详细描述

  1. Prospective, singlecenter, open label, randomized controlled study
  2. Eligible patients with chronic limb-threatening ischemia (Rutherford category 5) undergoing endovascular treatment for anterior tibial artery or posterior tibial artery lesions will be randomized to pressure wire-guided or angiography-guided groups.
  3. All patients will undergo balloon angioplasty for anterior or posterior tibial artery lesions, with the angiography-guided group aiming for optimal procedural results based on angiography, and the pressure wire-guided group aiming for optimal results based on both angiography and pressure gradient measurements.
  4. The primary efficacy endpoint is attainment of skin perfusion pressure ≥50 mmHg within 1-3 days after the procedure.
  5. Clinical follow-up will occur at 1, 3, and 6 months to assess wound healing and clinical events.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with chronic limb threatening ischemia (Rutherford 5)
  • Anterior tibial artery or posterior tibial artery lesions ≥ 10 cm Age ≥19 years

排除标准

  • Acute limb ischemia
  • Contraindication to antiplatelet or anticoagulation agents:
  • Thrombocytopenia (platelet <100,000/uL)
  • Previous cerebral hemorrhage, GI bleeding, other reasons for increased bleeding risk within 6 months
  • Pregnant women or women with potential childbearing
  • Life expectancy < 1 year

结局指标

主要结局

Attainment rate of postprocedural skin perfusion pressure ≥50 mmHg

时间窗: Attainment rate of postprocedural skin perfusion pressure≥50 mmHg within 3 days after the indez endovascular therapy

within 3 days after the index endovascular therapy

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验